6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
18D78
23-25
Nov
2026
CPHI India 2026
IICC, Yashobhoomi, Dwarka, Delhi
1C44

Axa Parenterals Ltd

About Axa Parenterals Ltd

Axa Parenterals Limited (APL) and it’s 100% subsidiary Heilsa Life Sciences (HLS) has applied for EUGMP. APL with 4 Rommelag filling machine  &  PIC/S, WHO-GMP approval is exporting in 61 countries. APL is in respules, single use eye drop (Unims), multidose eye drops and LVP. HLS is into manufacturing of General Injectable Vial–Emulsion, Liposomal and lyophilized; PFS & ampoules. Key Products-Propofol, Liposomal amphotericin B, Enoxaparin, Heparin, Levetiracetam, Milirinone,  Pantoprazole-lyophilized. We  seek CDMO/Marketing alliance in Europe and around globe.

Certifications

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • CPHI India 2026

    IICC, Yashobhoomi, Dwarka, Delhi
    23 Nov 2026 - 25 Nov 2026
  • Country/Region:
    India
  • On CPHI since:
    2019
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Contact info
  • Puhana Chowk ,Vill:Kishnapur- Jamalpur, Dist : Haridwar ,, 247669, Roorkee , Uttarakhand, India

Products from Axa Parenterals Ltd (5)

Axa Parenterals Ltd Resources (1)